Khan, N. (2025) “Prospective Evaluation of Atrial Fibrillation Risk in Type 2 Diabetes Comparing SGLT-2 Inhibitors and DPP-4 Inhibitors”, Indus Journal of Bioscience Research, 3(3), pp. 69–75. doi:10.70749/ijbr.v3i3.797.